Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts

Clinical outcomes (CO) for special populations of patients (pts) with advanced non-small cell lung cancer (NSCLC): Results from ARIES, a bevacizumab (BV) observational cohort study (OCS).

(2017) A. J. Wozniak et al.   JOURNAL OF CLINICAL ONCOLOGY

Baseline (BL) radiographic characteristics and severe pulmonary hemorrhage (SPH) in bevacizumab (BV)-treated non-small cell lung cancer (NSCLC) patients (pt): Results from ARIES, an observational cohort study (OCS).

(2017) P. Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study

(2011) N B Leighl et al.   BRITISH JOURNAL OF CANCER

Treatment-Related Mortality With Bevacizumab in Cancer Patients

(2011) Vishal Ranpura et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors

(2010) F. Barlesi et al.   ANNALS OF ONCOLOGY

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) G. D'Addario et al.   ANNALS OF ONCOLOGY

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

(2010) M. Reck et al.   ANNALS OF ONCOLOGY

Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma

(2010) Manuela Schmidinger et al.   CANCER TREATMENT REVIEWS

Radiological Management of Hemoptysis: A Comprehensive Review of Diagnostic Imaging and Bronchial Arterial Embolization

(2010) Joo-Young Chun et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL)

(2010) Natasha B. Leighl et al.   Journal of Thoracic Oncology

BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer

(2010) John D. Hainsworth et al.   Journal of Thoracic Oncology

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

(2010) MP Coleman et al.   LANCET

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

(2010) Lucio Crinò et al.   LANCET ONCOLOGY

Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity

(2010) Marian Reinfuss et al.   LUNG CANCER

Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis

(2010) Sanjaykumar Hapani et al.   ONCOLOGY

Surgical Lung Resection for Severe Hemoptysis

(2009) Claire Andréjak et al.   ANNALS OF THORACIC SURGERY

Multidisciplinary Management of Life-Threatening Massive Hemoptysis: A 10-Year Experience

(2009) Norihisa Shigemura et al.   ANNALS OF THORACIC SURGERY

A prospective evaluation of hemoptysis cases in a tertiary referral hospital

(2009) Oğuz Uzun et al.   Clinical Respiratory Journal

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

(2009) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab

(2009) Alan B. Sandler et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

(2009) RuiRong Yuan et al.   Journal of Hematology & Oncology

Bronchial Artery Embolization for the Management of Hemoptysis in Oncology Patients: Utility and Prognostic Factors

(2009) Gin R. Wang et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Use of Multidetector Row CT to Evaluate the Need for Bronchial Arterial Embolization in Hemoptysis Patients

(2009) Hidenori Mori et al.   RESPIRATION

Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review

(2008) Alysa Fairchild et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer

(2008) Simon J. Crabb et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Cavitation During Therapy with Antiangiogenesis Agents in Patients with Lung Cancer

(2008) Edith M. Marom et al.   Journal of Thoracic Oncology

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

(2007) Suresh S. Ramalingam et al.   JOURNAL OF CLINICAL ONCOLOGY